combining glp-1 with sglt2 inhibitors to treat patients with type 1 diabetes, bmi more than 25 kg/m2, and chronic kidney disease: a randomised, controlled trial

E. Alozairi; E. Taghadom; M. Irshad; A. Al Yousef; J. Alkandari; W. Al-Najim; S. Alabdulkader; A. D. Miras; C. W. le Roux

combining glp-1 with sglt2 inhibitors to treat patients with type 1 diabetes, bmi more than 25 kg/m², and chronic kidney disease: a randomised, controlled trial

E. Alozairi
, E. Taghadom
, M. Irshad
, A. Al Yousef
, J. Alkandari
, W. Al-Najim
, S. Alabdulkader
, A. D. Miras
, C. W. le Roux

Dasman Diabetes Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Pages (from-to)	S519-S520
Journal	Diabetologia
Volume	67
State	Published - 2024

Funding Agency

Kuwait Foundation for the Advancement of Sciences

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{ebc977666b4746c788544f5e4a0de700,

title = "combining glp-1 with sglt2 inhibitors to treat patients with type 1 diabetes, bmi more than 25 kg/m2, and chronic kidney disease: a randomised, controlled trial",

author = "E. Alozairi and E. Taghadom and M. Irshad and \{Al Yousef\}, A. and J. Alkandari and W. Al-Najim and S. Alabdulkader and Miras, \{A. D.\} and \{le Roux\}, \{C. W.\}",

year = "2024",

language = "American English",

volume = "67",

pages = "S519--S520",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - combining glp-1 with sglt2 inhibitors to treat patients with type 1 diabetes, bmi more than 25 kg/m2, and chronic kidney disease: a randomised, controlled trial

AU - Alozairi, E.

AU - Taghadom, E.

AU - Irshad, M.

AU - Al Yousef, A.

AU - Alkandari, J.

AU - Al-Najim, W.

AU - Alabdulkader, S.

AU - Miras, A. D.

AU - le Roux, C. W.

PY - 2024

Y1 - 2024

M3 - Article

SN - 0012-186X

VL - 67

SP - S519-S520

JO - Diabetologia

JF - Diabetologia

ER -